Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.

Abstract: The present invention is in the field of extraction a product for liquid absorption comprising a low-density biopolymer, such as obtainable from a granular sludge, in particular alginate or bacterial alginate, wherein the biobased polymer acts as a super-absorbing material, and a method of obtaining said product.

Abstract: In a prior art reactor set up dense aggregates of microorganisms are formed, typically in or embedded in an extra cellular matrix. Such may relate to granules, to sphere like entities having a higher viscosity than water, globules, a biofilm, etc. The dense aggregates comprise extracellular polymeric substances, or biopolymers, in particular linear polysaccharides, The present invention is in the field of extraction a biopolymer from a granular sludge, a fibrous biopolymer obtained by said process, in particular alginate or bacterial alginate, and a use of said biopolymer.

Abstract: A composition for forming a bio-compatible membrane applicable to building material, such as concrete, cement, etc., to a method of applying said composition for forming a biocompatible membrane, a biocompatible membrane, use of said membrane for various purposes, and to building material comprising said membrane.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.

Abstract: In a prior art reactor set up dense aggregates of microorganisms are formed, typically in or embedded in an extra cellular matrix. Such may relate to granules, to sphere like entities having a higher viscosity than water, globules, a biofilm, etc. The dense aggregates comprise extracellular polymeric substances, or biopolymers, in particular linear polysaccharides, The present invention is in the field of extraction a biopolymer from a granular sludge, a fibrous biopolymer obtained by said process, in particular alginate or bacterial alginate, and a use of said biopolymer.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.

Abstract: A composition for forming a bio-compatible membrane applicable to building material, such as concrete, cement, etc., to a method of applying said composition for forming a biocompatible membrane, a biocompatible membrane, use of said membrane for various purposes, and to building material comprising said membrane.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition for parenteral administration comprising: an aqueous solution comprising ketorolac or a pharmaceutically acceptable salt thereof in an amount from about 0.1 mg/mL to about 10 mg/mL; and a pharmaceutically acceptable excipient; wherein the formulation is substantially free of alcohol.

Abstract: Disclosed is a polymer electrolyte for use in an electrochemical device. Said polymer electrolyte comprises at least one polymer having ion-exchangeable functional groups. The polymer also comprises ionic liquid functional groups. The ion-exchangeable functional groups comprise a polymer-bound anionic group, such as a sulfonate, a carboxylate, and a phosphonate or any anionic surfactant group. Also disclosed is an electrical device that comprises said polymer electrolyte material. Such electrical device preferably consists of a fuel cell, an electrical battery, a super capacitor, an electrochromic window or a solar cell.

Abstract: A method is disclosed for sensing fault-fault relationships, comprising: automatically sensing interrelationships among faults, and presenting a final model including a fault-fault intersection curve and one fault truncated at the curve to an interpreter representing the interrelationships among faults.

Abstract: A decorative display device comprising an electrically energized lamp, a pair of concentric lampshades surrounding the light bulb. The pair of concentric lampshades are configured so as to create a continuous airspace between the inner and outer lampshades. The outer lampshade has one or more apertures at predetermined locations, the apertures being shaped for a desired design. The outer lampshade has pictorial representation representing a predetermined theme. Inner lampshade pictorial representations are located so as to be viewable through the apertures in the outer lampshade. The inner or outer lampshades are configured with support arms to rotate relative to each other. Caricatures can be supported on arms and located in between the inner and outer lampshades for rotation therebetween to enhance the desired theme. The caricatures can also be made to oscillate up and down.

Abstract: The invention is directed to a liquid crystalline display comprising a display cell containing liquid crystalline material and a retardation layer. The retardation layer comprises a, preferably slightly cross-linked, high-molecular weight material layer and a substrate, wherein the high-molecular weight material has a nematic phase above its Tg and a dynamic viscosity at the working temperature of at least 100 Pa.s. The difference of the Tc of the high-molecular weight material and the Tc of the low-molecular weight material of the display cell (TC.sub.cell) is in the range of -30.degree. C. to +30.degree. C., preferably in the range of -20.degree. C. to +20.degree. C., and more preferably in the range of -10.degree. C. to +10.degree. C.; and the Tg of the high-molecular weight liquid crystalline material is lower than 50.degree. C.

Abstract: A snowfall simulator which houses and dispenses artificial snow from a box-like housing 20 using agitation. The housing or dispenser has openings 32 uniformly placed on the bottom horizontal plane. Thin shredded white plastic flakes, used for snow, are placed inside and the machine which is mounted directly over the desired area. A small motor 14 is attached to the housing. A light-weight reticulated agitation plate 24, fastened to a support rod 25, resting on the inside bottom horizontal plane of housing, is pivotally connected by gear 16 and shaft 18 to motor. A series of rods 29 and paddles 31 are pivotally attached to rod 25. A series of slats are fastened to the sides of housing, just above, and perpendicular to, the agitation plate 24 and rod 25. The linear motion of the grid 24, rod 25, and push rods 29 and paddles 31, works to slowly agitate the snow flake material out of the housing through the exit holes and onto the window display, theatrical stage, display case, or event.

Abstract: The invention is in the field of retardation layers comprising high-molecular weight liquid-crystalline material for liquid-crystalline displays. The invention is directed to a retardation layer for a liquid-crystalline display comprising high-molecular weight liquid-crystalline material, wherein the dispersion has been adapted to that of the active liquid-crystalline cell by varying the mesogenic groups of the high-molecular weight liquid-crystalline material, so that the difference in dispersion between the active cell and the retardation layer in the wavelength area of 400-800 nm is not more than 0.1.